Covered recipient · General Payments record
MITRA HANJANI
Allopathic & Osteopathic Physicians Internal Medicine
General Payments · PY2018–2024
$667.95
- Reported across 34 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $209.19 | 10 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $65.01 | 3 |
| Lilly USA, LLC | $50.14 | 2 |
| Bayer HealthCare Pharmaceuticals Inc. | $36.40 | 2 |
| Novo Nordisk AS | $34.86 | 2 |
| Xeris Pharmaceuticals, Inc. | $22.78 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (10)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $17.93 | 01/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103874330 | CMS |
| ABBVIE INC. | $28.57 | 02/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103874332 | CMS |
| ABBVIE INC. | $18.51 | 08/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103874334 | CMS |
| Bayer Healthcare Pharmaceuticals Inc. | $20.27 | 01/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1086109456 | CMS |
| Bayer Healthcare Pharmaceuticals Inc. | $16.13 | 08/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1086109452 | CMS |
| Lilly USA, LLC | $25.40 | 05/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135244223 | CMS |
| Lilly USA, LLC | $24.74 | 08/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135212801 | CMS |
| Novo Nordisk Inc | $16.13 | 04/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097752358 | CMS |
| Novo Nordisk Inc | $18.73 | 07/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096653072 | CMS |
| Xeris Pharmaceuticals, Inc. | $22.78 | 09/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144606538 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2021, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.